| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 107660 | Actinomycin Pip T.beta. | 0.000108541161925035 | 0.2173049 |
| NSC 688235 | Null | 0.000120353817593339 | 0.35372847 |
| NSC 641390 | Null | 0.000124425989776296 | 0.27297898 |
| NSC 687330 | Adenosine, 2'-amino-2'-deoxy-3',5'- O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]- (9CI) | 0.000152553454647253 | 0.45103458 |
| NSC 711611 | Null | 0.000152553454647253 | 0.32763097 |
| NSC 725191 | 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol | 0.000152553454647253 | 0.34971397 |
| NSC 736164 | pyrazoline derivative | 0.000152553454647253 | 0.41407534 |
| NSC 740385 | 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide | 0.000152553454647253 | 0.55915958 |
| NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 0.000152553454647255 | 0.3331928 |
| NSC 291330 | Null | 0.000152553454647255 | 0.26190887 |